Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
Location: Canada
Employees: 51-200
Total raised: $75M
Founded date: 2014
Investors 3
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
| - | OrbiMed | orbimed.co... |
| - | Adams Stre... | adamsstree... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.09.2015 | Series B | $75M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 13.03.2024 | Corvus Pharmaceuticals to Provide Business Update and Fourth... | - | globenewsw... |
| 27.09.2022 | Angel Pharmaceuticals Announces Approval of IND Application ... | JIAXING,China and BURLINGAME,Calif., Sept. 27, 2022 /PRNewswire/ -- Angel Pharmaceuticals Ltd. (&quo... | en.prnasia... |
| 26.10.2021 | Angel Pharmaceuticals Announces Approval of IND Application ... | JIAXING, China and BURLINGAME, Calif., Oct. 26, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd.... | en.prnasia... |
| 17.08.2021 | Angel Pharmaceuticals Announces IND Acceptance for Clinical ... | JIAXING, China and BURLINGAME, Calif., Aug. 17, 2021 /PRNewswire/ -- Angel Pharmaceuticals Ltd. (&qu... | en.prnasia... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 04.01.2016 | Biotech Startups Hit the Ground Running, With Six Filing IPO... | If we had to gamble on it, we’d bet the IPO market will be far more brisk this year than last year, ... | techcrunch... |
| 29.09.2015 | Corvus Pharmaceuticals Closes $75M Series B Financing | Corvus Pharmaceuticals, a Burlingame, CA-based clinical-stage biopharmaceutical company focused on t... | finsmes.co... |
| 25.09.2015 | Former Pharmacyclics CEO raises $75M Series B for new immuno... | This new round, ostensibly a Series B, has 33 investors participating. The company has yet to return... | medcitynew... |
| - | Former Pharmacyclics CEO raises $75M Series B for new immuno... | Bay area immuno-oncology startup Corvus Pharmaceuticals just raised an impressive $75 million, SEC f... | medcitynew... |